Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-53,887
Closed -$2.42M 391
2025
Q3
$2.42M Buy
53,887
+4,011
+8% +$189K 0.11% 135
2025
Q2
$2.45M Buy
49,876
+13,230
+36% +$740K 0.12% 134
2025
Q1
$2.07M Buy
36,646
+1,629
+5% +$91.7K 0.11% 133
2024
Q4
$2.01M Buy
35,017
+6,548
+23% +$373K 0.1% 144
2024
Q3
$1.49M Buy
28,469
+8,273
+41% +$430K 0.08% 162
2024
Q2
$1.09M Buy
20,196
+12,733
+171% +$695K 0.06% 164
2024
Q1
$432K Buy
+7,463
New +$384K 0.02% 214

Other funds holding CPRT

Trilogy Capital's CPRT Position: Q4 2025 in Review

Trilogy Capital sold out of Copart (CPRT) in Q4 2025, closing a stake of 53,887 shares — an estimated $2.42M sold.

Trilogy Capital first reported a position in CPRT in Q1 2024 and held it in 7 quarters. The position peaked at $2.45M in Q2 2025. 1,142 funds tracked by Wall St. Rank hold CPRT as of Q4 2025.

  • Trilogy Capital reported no remaining Copart position as of Q4 2025 after selling out during the quarter.
  • Trilogy Capital sold 53,887 Copart shares in Q4 2025, an estimated $2.42M.
  • Trilogy Capital first reported a position in Copart in Q1 2024 and held it in 7 quarters.
  • Trilogy Capital's Copart position peaked at $2.45M in Q2 2025.
  • 1,142 funds tracked by Wall St. Rank held Copart as of Q4 2025.

Based on Trilogy Capital's 13F filing for Q4 2025, filed 22 Jan 2026.